Laurus Labs reports approval by unsecured creditors of Composite Scheme of Arrangement
Laurus Labs · Pharmaceuticals & Biotechnology
Key highlights
- Meetings of unsecured creditors of Laurus Synthesis Pvt Ltd and Sriam Labs Pvt Ltd held on April 06, 2026
- Requisite quorum present and meetings conducted fairly and transparently as per NCLT directions
- Unsecured creditors approved the Composite Scheme; scheme now subject to NCLT and regulatory approvals
Why it's rated notable: The filing states creditor approval of an intra-group composite scheme with no value stated and NCLT approval still pending, so the level is capped at medium.
Original filing
Update On Meetings Of Unsecured Creditors In Relation To The Composite Scheme Of Arrangement
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Laurus Labs
- Acquisition / mergerMajor developmentLaurus Labs reports Q2 & H1 FY27 results; signs deal for 60% stake in Galenvs Sciences
Other acquisition / merger filings this fortnight
- IndiGrid Infrastructure Trust Q2 FY27 Earnings Conference Call Transcript Released
- Cubical Financial Services Ltd announces promoter reclassification post open offer
- Novus Loyalty Limited approves acquisition of AutoPe Payment Solutions via share swap
- Shish Industries Limited files Composite Scheme of Amalgamation proposal
- Jubilant Ingrevia Limited updates on acquisition of 40% stake in Zettaone Technologies
- NHC Foods approves quarter results, 99.98% Sachmaas Foods investment, two appointments
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.